Visfatin, a potential biomarker and prognostic factor for endometrial cancer (Q86200525)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Visfatin, a potential biomarker and prognostic factor for endometrial cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Wenyan Tian

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Yuanxi Zhu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Fei Teng

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Huiying Zhang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Guoyan Liu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Xuegong Ma

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Dandan Sun

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Thomas Rohan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Fengxia Xue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

22 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

505-512

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

The Link between the Metabolic Syndrome and Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Could serum visfatin be a potential biomarker for postmenopausal breast cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Insulin resistance: a significant risk factor of endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Nicotinamide Phosphoribosyltransferase in Human Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

A novel role for the adipokine visfatin/pre-B cell colony-enhancing factor 1 in prostate carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Mitogenic and anti-apoptotic effects of insulin in endometrial cancer are phosphatidylinositol 3-kinase/Akt dependent.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Insulin promotes proliferation, survival, and invasion in endometrial carcinoma by activating the MEK/ERK pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Revised FIGO staging for carcinoma of the endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Metabolic syndrome and endometrial cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Understanding obesity and endometrial cancer risk: opportunities for prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Metformin: a potential novel endometrial cancer therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

High visfatin expression in breast cancer tissue is associated with poor survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Gene expression profile associated with response to doxorubicin-based therapy in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Visfatin stimulates proliferation of MCF-7 human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

Nampt: linking NAD biology, metabolism and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.022

10.1016/J.YGYNO.2013.02.022

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438672%20AND%20SRC:MED&resulttype=core&format=json